Omeros (OMER) EBIT Margin Growth (3y) (2013 - 2022)
Omeros (OMER) EBIT Margin Growth (3y) (2013 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 828,504.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7,261.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -50,506.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -2,649.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 9,003.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 30,461.00 |
| 10 | Omeros | 1.24 Bn | 1.24 Bn | 27.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -33,570.00 |
| Mar 31, 2022 | -41,261.00 |
| Dec 31, 2021 | 13,759.00 |
| Sep 30, 2021 | 63,640.00 |
| Jun 30, 2021 | 169,173.00 |
| Mar 31, 2021 | 152,860.00 |
| Dec 31, 2020 | -21,544.00 |
| Sep 30, 2020 | -7,378.00 |
| Jun 30, 2020 | -13,497.00 |
| Mar 31, 2020 | 322.00 |
| Dec 31, 2019 | 2,095.00 |
| Sep 30, 2019 | 6,945.00 |
| Jun 30, 2019 | 7,434.00 |
| Mar 31, 2019 | 17,385.00 |
| Dec 31, 2018 | 18,635.00 |
| Sep 30, 2018 | -17,690.00 |
| Jun 30, 2018 | -134,897.00 |
| Mar 31, 2018 | 287,749.00 |
| Dec 31, 2017 | 1.10 Mn |
| Sep 30, 2017 | 798,201.00 |